Humanized SRC SCID Mice

  • Check with publisher
  • Published date: February 11, 2020
    • Shirley, New York, United States

“Humanized” mouse model of immunity refers to normal, immunocompetent mouse expressing human genes by transgenesis (such as HLA or human immunoglobulin transgenic mice) or to immunodeficient mouse engrafted with human hematopoietic and lymphoid cells or tissues. Immunodeficient mice engrafted with human cells/tissues have provided a potential approach for the study of human immunobiology. The humanized SRC-SCID model is established by injecting newborn or adult immunodeficient mice with HSCs from a variety of sources and has been regarded as a supreme in vivo model for long-term studies in the fields of immuno-oncology, infectious disease, and graft versus host disease. With years of experience in animal model, Creative Biolabs can provide the validated humanized SRC SCID mice for our worldwide clients to evaluate the safety and efficacy of potential novel agents to modulate the immune system. https://www.creative-biolabs.com/drug-discovery/therapeutics/humanized-src-scid-mice.htm

Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • PLGA, Poly(lactic-co-glycolic acid)s

    PLGA, Poly(lactic-co-glycolic acid)s

    Biomedical Sciences Shirley (New York) November 24, 2020 Check with publisher

    Solid phase drug delivery/implantable systems, CD Bioparticles provides PLGA, Poly(lactic-co-glycolic acid)s with a PLGA molecular weight of Mw 55,000-65,000 Da DL for drug delivery. https://www.cd-bioparticles.net/p/496/plga

  • PLGA-DPE, Poly(lactic-co-glycolic acid)s

    PLGA-DPE, Poly(lactic-co-glycolic acid)s

    Biomedical Sciences Shirley (New York) November 24, 2020 Check with publisher

    Solid phase drug delivery/implantable systems. CD Bioparticles provides PLGA-DPE, Poly(lactic-co-glycolic acid)s with a PLGA molecular weight of Mw 40,000 -60,000 Da for drug delivery. https://www.cd-bioparticles.net/p/485/plga-dpe.

  • PLGA, Poly(lactic-co-glycolic acid)s

    PLGA, Poly(lactic-co-glycolic acid)s

    Biomedical Sciences Shirley (New York) November 24, 2020 Check with publisher

    Solid phase drug delivery/implantable systems. CD Bioparticles provides PLGA, Poly(lactic-co-glycolic acid)s with a PLGA molecular weight of Mw 35,000-45,000 Da DL for drug delivery. https://www.cd-bioparticles.net/p/472/plga